Figure 7. Vitamin D Promotes EPSC Maintenance by Regulating Metabolic Pathways.
(A) Venn diagram of genes that were regulated by 1,25-(OH)2D3 treatment (top) or MLL1i/1,25-(OH)2D3 treatment (bottom). Genes were selected by FDR % 0.05 and |FC|≥1.5 compared with untreated ESCs.
(B and C) Venn diagram for genes (FDR ≤ 0.05 and |FC| ≥1.5) upregulated (B) or downregulated (C) by MLL1i/Mll1KO, 1,25-(OH)2D3 or MLL1i/1,25-(OH)2D3. Percentage refers to genes in each category versus all genes that changed expression in three scenarios.
(D) GO term analysis for upregulated gene pathways after MLL1i, 1,25-(OH)2D3 or MLL1i/1,25-(OH)2D3 treatment, as indicated on the bottom. The —log10 p value is presented in the heatmap.
(E) GO term analysis for downregulated gene pathways after MLL1i, 1,25-(OH)2D3, or MLL1i/1,25-(OH)2D3 treatment, as indicated on the bottom. The —log10 p value is presented in the heatmap.